MeiraGTx Holdings plc Increase (Decrease) in Prepaid Expense
MeiraGTx Holdings plc (MGTX) reported Increase (Decrease) in Prepaid Expense of -$2.04 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2026-08-13
- MeiraGTx Holdings plc increase (decrease) in prepaid expense for the quarter ending 2026-06-30 was -$2.08M.
- MeiraGTx Holdings plc increase (decrease) in prepaid expense for the quarter ending 2026-03-31 was $42.00K.
- MeiraGTx Holdings plc increase (decrease) in prepaid expense for the quarter ending 2025-12-31 was -$833.00K, a 2235.90% decline year-over-year.
- MeiraGTx Holdings plc increase (decrease) in prepaid expense for the quarter ending 2025-09-30 was $257.00K, a 86.77% decline year-over-year.
- MeiraGTx Holdings plc increase (decrease) in prepaid expense for fiscal 2025 was -$720.00K, a 154.22% decline from fiscal 2024.
- MeiraGTx Holdings plc increase (decrease) in prepaid expense for fiscal 2024 was $1.33M.
- MeiraGTx Holdings plc increase (decrease) in prepaid expense for fiscal 2023 was -$2.69M, a 917.63% decline from fiscal 2022.
- MeiraGTx Holdings plc increase (decrease) in prepaid expense for fiscal 2022 was $329.00K, a 69.62% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 3 month as first filed | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 6 month as first filed | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 9 month as first filed | Increase (Decrease) in Prepaid Expense 12 month | Increase (Decrease) in Prepaid Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$2.04M 10-Q · filed 2026-08-13 | -$2.87M derived: sum of 3 quarters · filed 2026-08-13 | -$2.62M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $42.00K 10-Q · filed 2026-05-14 | -$791.00K derived: sum of 2 quarters · filed 2026-05-14 | -$534.00K derived: sum of 3 quarters · filed 2026-05-14 | -$671.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$833.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$576.00K derived: sum of 2 quarters · filed 2026-03-30 | -$713.00K derived: sum of 3 quarters · filed 2026-08-13 | -$720.00K 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | $257.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $120.00K derived: sum of 2 quarters · filed 2026-08-13 | $113.00K 10-Q · filed 2025-11-13 | $152.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$137.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$144.00K 10-Q · filed 2026-08-13 | -$105.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.84M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$7.00K 10-Q · filed 2026-05-14 | $32.00K derived: sum of 2 quarters · filed 2026-05-14 | $1.98M derived: sum of 3 quarters · filed 2026-05-14 | $1.85M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.98M derived: sum of 2 quarters · filed 2026-03-30 | $1.86M derived: sum of 3 quarters · filed 2026-03-30 | $1.33M 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | $1.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.82M derived: sum of 2 quarters · filed 2025-11-13 | $1.29M 10-Q · filed 2025-11-13 | -$189.00K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$124.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$654.00K 10-Q · filed 2025-08-14 | -$2.13M derived: sum of 3 quarters · filed 2025-08-14 | -$3.15M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$530.00K 10-Q · filed 2025-05-13 | -$2.01M derived: sum of 2 quarters · filed 2025-05-13 | -$3.02M derived: sum of 3 quarters · filed 2025-05-13 | -$1.99M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | -$1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$2.49M derived: sum of 2 quarters · filed 2025-03-13 | -$1.46M derived: sum of 3 quarters · filed 2025-03-13 | -$2.69M 10-K · filed 2025-03-13 | ||||
| 2023-09-30 | -$1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $23.00K derived: sum of 2 quarters · filed 2024-11-13 | -$1.21M 10-Q · filed 2024-11-13 | -$3.72M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$198.00K 10-Q · filed 2024-08-12 | -$2.71M derived: sum of 3 quarters · filed 2024-08-12 | $1.14M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | -$1.24M 10-Q · filed 2024-05-09 | -$3.74M derived: sum of 2 quarters · filed 2024-05-09 | $103.00K derived: sum of 3 quarters · filed 2024-05-09 | -$126.00K derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$2.51M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $1.34M derived: sum of 2 quarters · filed 2024-03-15 | $1.11M derived: sum of 3 quarters · filed 2024-03-15 | $329.00K 10-K · filed 2024-03-15 | ||||
| 2022-09-30 | $3.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $3.62M derived: sum of 2 quarters · filed 2023-11-14 | $2.84M 10-Q · filed 2023-11-14 | $2.09M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$229.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$1.01M 10-Q · filed 2022-08-11 | -$1.75M derived: sum of 3 quarters · filed 2022-08-11 | $694.00K derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2022-03-31 | -$780.00K 10-Q · filed 2022-05-12 | -$1.52M derived: sum of 2 quarters · filed 2022-05-12 | $923.00K derived: sum of 3 quarters · filed 2022-05-12 | $1.04M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-12-31 | -$744.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $1.70M derived: sum of 2 quarters · filed 2022-03-10 | $1.82M derived: sum of 3 quarters · filed 2022-08-11 | $1.08M 10-K · filed 2022-03-10 | ||||
| 2021-09-30 | $2.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $2.57M derived: sum of 2 quarters · filed 2022-08-11 | $1.83M 10-Q · filed 2021-11-10 | $4.73M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-06-30 | $119.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$620.00K 10-Q · filed 2022-08-11 | $2.28M derived: sum of 3 quarters · filed 2022-08-11 | -$1.32M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | -$739.00K 10-Q · filed 2022-05-12 | $2.16M derived: sum of 2 quarters · filed 2022-05-12 | -$1.44M derived: sum of 3 quarters · filed 2022-05-12 | $2.46M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$698.00K derived: sum of 2 quarters · filed 2022-03-10 | $3.19M derived: sum of 3 quarters · filed 2022-03-10 | $2.37M 10-K · filed 2022-03-10 | $2.37M 10-K · filed 2021-03-11 | |||
| 2020-09-30 | -$3.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $293.00K derived: sum of 2 quarters · filed 2021-11-10 | -$535.00K 10-Q · filed 2021-11-10 | -$535.21K 10-Q · filed 2020-11-05 | -$2.69M derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | $3.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $3.06M 10-Q · filed 2021-08-11 | $3.06M 10-Q · filed 2020-08-06 | $910.63K derived: sum of 3 quarters · filed 2021-08-11 | $3.99M derived: sum of 4 quarters · filed 2021-08-11 | |||
| 2020-03-31 | -$828.00K 10-Q · filed 2021-05-11 | -$827.98K 10-Q · filed 2020-05-07 | -$2.98M derived: sum of 2 quarters · filed 2021-05-11 | $100.20K derived: sum of 3 quarters · filed 2021-05-11 | $1.62M derived: sum of 4 quarters · filed 2021-05-11 | |||
| 2019-12-31 | -$2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $928.20K derived: sum of 2 quarters · filed 2021-03-11 | $2.45M derived: sum of 3 quarters · filed 2021-03-11 | $2.26M 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | $3.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $4.60M derived: sum of 2 quarters · filed 2020-11-05 | $4.41M 10-Q · filed 2020-11-05 | $4.34M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $1.33M 10-Q · filed 2020-08-06 | $1.25M derived: sum of 3 quarters · filed 2020-08-06 | $1.68M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | -$188.04K 10-Q · filed 2020-05-07 | -$265.02K derived: sum of 2 quarters · filed 2020-05-07 | $164.55K derived: sum of 3 quarters · filed 2020-05-07 | -$973.64K derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | -$76.97K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $352.60K derived: sum of 2 quarters · filed 2020-03-11 | -$785.60K derived: sum of 3 quarters · filed 2020-03-11 | $35.47K 10-K · filed 2020-03-11 | ||||
| 2018-09-30 | $429.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$708.62K derived: sum of 2 quarters · filed 2019-11-07 | $112.44K 10-Q · filed 2019-11-07 | |||||
| 2018-06-30 | -$1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$317.13K 10-Q · filed 2019-08-07 | ||||||
| 2018-03-31 | $821.06K 10-Q · filed 2019-05-14 | |||||||
| 2017-12-31 | $669.76K 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |